Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Trademark Information
Application ID
Status
Sub Status
Date of Application
23 December 2002
Classes
5
Attorney
Nanavati & Nanavati Advocates[2789]
7th Floor, Corporate House, Sarkhej Gandhinagar Highway, Judges Bunglows Cross Road, Bodakdev, Ahmedabad 380054, Gujarat
Type
Word
State
Gujarat
Country
Filing Mode
Branch Office
IP Office
AHMEDABAD
Used Since
Valid / Upto
23 December 2032
Description
[Class : 5] Medicinal, Pharmaceutical And Veterinary Preparations, Substances And Products Including But Not Limited To) Antibiotic Formulations, Medicinal And Pharmaceutical Preparations, Substances And Products Used For/For The Treatment Of Infections.
PR Details
Pursuant To A Request On Form Tm 24 Dated 09/09/2011 And Order Thereon Dated 08/02/2013 Alembic Pharmaceuticals Limited Has Been Brought On Record As Subsequent Proprietor In Respect Of The Said Registered Trade Mark By Virtue Of Order Of Gujarat High Court Dated 24/01/2011 W.E.F. 01/04/2011, Certificate Of Incorporation Dated 31/05/199, 16/06/2010, 12/03/2011
Pursuant To A Request On Form Tm 50 Dated 02/02/2016 And Order Thereon Dated 28/03/2016 The Address For Service Is Altered To Nanavati & Nanavati Advocates , 7 Th Floor, Corporate House, Sarkhej Gandhinagar Highway, Judges Bunglows Cross Road, Bodakdev, Ahmedabad 380054, Gujarat
Registration Renewed For A Period Of 10 Years From 23/12/2012 Advertised In Journal No. 1739
Registration Renewed For A Period Of 10 Years From 23/12/2022 Advertised In Journal No. 2085
Sign In to Follow Application
All Documents & Correspondence
All Documents & Correspondence
Uploaded Documents
| 2 | File Cover | 23 Dec 2002 |
| 2 | TM-1 | 23 Dec 2002 |
| 3 | Additional Representation Sheet | 23 Dec 2002 |
| 3 | File Cover | 23 Dec 2002 |
| 4 | Additional Representation Sheet | 23 Dec 2002 |
| 4 | TM-1 | 23 Dec 2002 |
| 6 | Examination Report | 02 May 2003 |
| 6 | Note Sheet | 02 May 2003 |
| 7 | Examination Report | 02 May 2003 |
| 7 | Note Sheet | 02 May 2003 |